back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-11-09 18:39 Tx date 2023-11-09 |
$PSYFP
GHP Noetic Science-Psychedelic Pharma Inc. |
Barbeau, Paul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$383,333
+1,533,333 vol $0.25 each |
1,666,666 | |
| Filed 2023-11-09 18:37 Tx date 2023-11-09 |
$PSYFP
GHP Noetic Science-Psychedelic Pharma Inc. |
Barbeau, Paul
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
$-8,333.25
-33,333 vol $0.25 each |
133,333 | |
| Filed 2023-11-09 18:28 Tx date 2023-11-09 |
$PSYFP
GHP Noetic Science-Psychedelic Pharma Inc. |
Barbeau, Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-10,000 vol |
40,000 | |
| Filed 2020-08-18 18:32 Tx date 2020-07-30 |
$PSYFP
GHP Noetic Science-Psychedelic Pharma Inc. |
Barbeau, Paul
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
166,666 | ||
| Filed 2020-08-11 13:31 Tx date 2020-08-11 |
$PSYFP
GHP Noetic Science-Psychedelic Pharma Inc. |
Franks, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$33,333
+166,666 vol $0.20 each |
166,666 | |
| Filed 2020-08-11 13:28 Tx date 2020-07-30 |
$PSYFP
GHP Noetic Science-Psychedelic Pharma Inc. |
Franks, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-08-11 12:02 Tx date 2020-08-11 |
$PSYFP
GHP Noetic Science-Psychedelic Pharma Inc. |
Jolley, Andrew
4 - Director of Issuer
Direct Ownership
|
Options
15 - Acquisition or disposition under a prospectus
|
$33,333
+166,667 vol $0.20 each |
166,667 | |
| Filed 2020-08-11 12:01 Tx date 2020-07-30 |
$PSYFP
GHP Noetic Science-Psychedelic Pharma Inc. |
Jolley, Andrew
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-08-11 12:00 Tx date 2020-08-11 |
$PSYFP
GHP Noetic Science-Psychedelic Pharma Inc. |
Main, George Iain Prentice
4 - Director of Issuer
Direct Ownership
|
Options
15 - Acquisition or disposition under a prospectus
|
$33,333
+166,667 vol $0.20 each |
166,667 | |
| Filed 2020-08-11 11:15 Tx date 2020-07-30 |
$PSYFP
GHP Noetic Science-Psychedelic Pharma Inc. |
Franks, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|